Efficacy of Clobazam as Add‐On Therapy in Patients with Refractory Partial Epilepsy

Abstract

We conclude that CLB may have efficacy equivalent to that of the new AEDs when used as add-on therapy in patients with refractory epilepsy. CLB should be considered an economic alternative in the treatment of patients with refractory epilepsy.